RA Capital Management Discloses 24.1% Stake in SpyGlass Pharma Following IPO
SGP is trading near its 52-week low of $24.71 (12% above the low).
Summary
RA Capital Management and its affiliates, including director Peter Kolchinsky, reported a substantial 24.1% beneficial ownership in SpyGlass Pharma, Inc. following the company's initial public offering.
Key Events · Ownership and Investor Activity · SGP
-
Major Institutional Ownership
RA Capital Management and its affiliates reported a 24.1% beneficial ownership in SpyGlass Pharma, holding 8,022,639 shares.
-
Significant Investment Post-IPO
The investment group acquired shares through pre-IPO preferred stock conversions and a $59 million purchase from underwriters at the IPO price of $16.00 per share, totaling over $100 million in aggregate investment.
-
Director Representation
Dr. Zachary Scheiner, a Principal of RA Capital, serves as a director on SpyGlass Pharma's board, aligning the investor's interests with company governance.
-
Investment Intent
The shares were acquired for investment purposes, with no current intent to change control, though future acquisitions or dispositions may occur based on market conditions and company prospects.
Analysis · SGP · Industrial Applications And Services
This Schedule 13D filing provides comprehensive details on the significant stake acquired by RA Capital Management and its affiliated funds in SpyGlass Pharma. The disclosure of a 24.1% beneficial ownership, valued at approximately $222 million based on today's stock price, signals strong institutional confidence in the newly public company. This follows a Form 4 filing on February 11, 2026, which indicated RA Capital's increased stake, and this 13D now provides the full scope of their holdings and investment intent. The involvement of a RA Capital principal, Dr. Zachary Scheiner, as a director further aligns the investor's interests with the company's strategic direction. The filing also outlines lock-up agreements and investors' rights, common for IPO-related investments, which govern future share dispositions and registration rights.
At the time of this filing, SGP was trading at $27.69 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $922.6M. The 52-week trading range was $24.71 to $29.47. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.